NATIONAL
CANCER
INSTITUTE

NCI Cancer Bulletin
A Trusted Source for Cancer Research News
November 18, 2008 • Volume 5 / Number 23 E-Mail This Document  |  Download PDF  |  Bulletin Archive/Search  |  Subscribe


Bulletin Home

Featured Article
NCI Technology Research Facility Gets Off the Ground

Cancer Research Highlights
Bevacizumab May Increase Blood Clot Risk

Number of Adult U.S. Smokers Drops, But So Do Quit Attempts

PAX2 Protein Mediates Effect of Tamoxifen in Breast Cancer

Burden of Cervical Cancer Prior to HPV Vaccine Assessed

Director's Update
Building an Advanced Technology Research Initiative

FDA Update
New Option Approved for Indolent NHL

Special Report
A Cancer Genome is Sequenced, Revealing Rare Mutations

Featured Clinical Trial
New Drug for Patients with Advanced Thyroid Cancer

Special Issue on Cancer Imaging

Spotlight
Cancer Disparities: A Biological and Psychosocial Perspective

Also in the Journals

Community Update
Researchers Consider "NCI Translates" Approach

Notes
NCI Advisors Approve Major Cancer Research Initiatives

Understanding NCI Teleconference: Translational Research Working Group

In Memoriam
Dr. Ronald M. Davis

Cancer Center Profile
Memorial Sloan-Kettering Cancer Center

Bulletin Archive

About the Bulletin

Page Options
Print This Page
Print This Document
View Entire Document
E-Mail This Document
View/Print PDF
In Memoriam: Dr. Ronald M. Davis

Dr. Ronald M. DavisAfter a 10-month battle with pancreatic cancer, Dr. Ronald M. Davis passed away November 6 at his home in East Lansing, MI.

Dr. Davis served as the 162nd president of the American Medical Association from June 2007 to June 2008. As the first preventive medicine specialist ever elected to that position, he focused on improving access to health care and the importance of prevention and sound public policy. He also helped lead the AMA's efforts to analyze its past history of racial inequality, which culminated in the organization's formal apology towards African American physicians in July 2008.

Dr. Davis' career as a public health official began as director of the CDC's Office on Smoking and Health, where he oversaw the publication of three landmark Surgeon General's reports on the health consequences of smoking and the health benefits of smoking cessation. He later served as medical director for the Michigan Department of Public Health and was most recently the director of the Center for Health Promotion and Disease Prevention at the Henry Ford Health System in Detroit.

From 1992-1998, Dr. Davis served as the founding editor of Tobacco Control, the first journal dedicated to tobacco control research, and later served as the North American editor of the British Medical Journal.

Dr. Davis was a key expert witness in many trials against the tobacco industry, and he testified before Congress and other legislative bodies on numerous occasions. His NCI grant, titled "Analysis of Tobacco Depositions and Trial Testimony," analyzed the sworn testimony of tobacco industry executives, researchers, and consultants.

He received many awards and honors, including the Surgeon General's Exemplary Service Medal and the Surgeon General's Medallion.

"He will be remembered by his colleagues and friends around the world for his seminal contributions to tobacco control and public health, as well as his kindness, integrity, and dedication to helping others," said Dr. Michele Bloch of NCI's Tobacco Control Research Branch.

< Previous Section  |  Next Section >


A Service of the National Cancer Institute
Department of Health and Human Services National Institutes of Health USA.gov